• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名中国进行性家族性肝内胆汁淤积症3型患者的新突变

Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.

作者信息

Sun Hao-Zhe, Shi Hong, Zhang Shun-Cai, Shen Xi-Zhong

机构信息

Hao-Zhe Sun, Hong Shi, Shun-Cai Zhang, Xi-Zhong Shen, Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

出版信息

World J Gastroenterol. 2015 Jan 14;21(2):699-703. doi: 10.3748/wjg.v21.i2.699.

DOI:10.3748/wjg.v21.i2.699
PMID:25593501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4292307/
Abstract

Genotyping is conclusive for the diagnosis of progressive familial intrahepatic cholestasis type 3 (PFIC3). Here we report a Chinese patient of PFIC3 with compound mutations in the ABCB4 gene. Liver biopsy was performed on a 17-year-old male patient with intrahepatic cholestasis of unknown etiology. Liver histology findings are indicative of intrahepatic cholestasis with extensive fibrosis. Genotyping revealed c.175C>T (p.L59L) mutation in exon 4, c.504C>T (p.N168N) mutation in exon 6, c.711A>T (p.I237I) mutation in exon 8, c.874A>T (p.K292X) in exon 9 and a novel mutation, c.1804G>T (p.G602W) in exon 15. Based on these findings, the patient was diagnosed with PFIC3. The novel mutation p.G602W in exon 15 was predicted as probably damaging by PolyPhen-2 with a score of 0.986 (sensitivity: 0.54; specificity: 0.94) and was predicted to affect protein function with a SIFT score of 0.01.

摘要

基因分型对于3型进行性家族性肝内胆汁淤积症(PFIC3)的诊断具有决定性意义。在此,我们报告1例ABCB4基因存在复合突变的中国PFIC3患者。对1例病因不明的肝内胆汁淤积症17岁男性患者进行了肝活检。肝脏组织学检查结果提示肝内胆汁淤积伴广泛纤维化。基因分型显示,第4外显子存在c.175C>T(p.L59L)突变,第6外显子存在c.504C>T(p.N168N)突变,第8外显子存在c.711A>T(p.I237I)突变,第9外显子存在c.874A>T(p.K292X)突变,以及1个新突变,第15外显子存在c.1804G>T(p.G602W)突变。基于这些发现,该患者被诊断为PFIC3。第15外显子的新突变p.G602W经PolyPhen-2预测可能具有损害性,得分0.986(敏感性:0.54;特异性:0.94),经SIFT评分预测会影响蛋白质功能,评分为0.01。

相似文献

1
Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.一名中国进行性家族性肝内胆汁淤积症3型患者的新突变
World J Gastroenterol. 2015 Jan 14;21(2):699-703. doi: 10.3748/wjg.v21.i2.699.
2
Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.中国一名进行性家族性肝内胆汁淤积症 3 型女性患者的新型 ABCB4 突变:病例报告。
Diagn Pathol. 2020 Apr 22;15(1):39. doi: 10.1186/s13000-020-00955-7.
3
Evaluation of a Novel Missense Mutation in Gene Causing Progressive Familial Intrahepatic Cholestasis Type 3.评估导致进行性家族性肝内胆汁淤积症 3 型的基因中的一种新型错义突变。
Dis Markers. 2020 Jun 15;2020:6292818. doi: 10.1155/2020/6292818. eCollection 2020.
4
[Clinical phenotype and genotype analysis of progressive familial intrahepatic cholestasis type 3 caused by novel ABCB4 gene mutation].新型ABCB4基因突变所致进行性家族性肝内胆汁淤积症3型的临床表型与基因型分析
Zhonghua Er Ke Za Zhi. 2024 Jul 2;62(7):649-654. doi: 10.3760/cma.j.cn112140-20240319-00190.
5
[Progressive familial intrahepatic cholestasis type 3].[进行性家族性肝内胆汁淤积症3型]
Dev Period Med. 2018;22(4):385-389. doi: 10.34763/devperiodmed.20182204.385389.
6
Molecular characterization of exons 6, 8 and 9 of ABCB4 gene in children with Progressive Familial Intrahepatic Cholestasis type 3.3型进行性家族性肝内胆汁淤积症患儿ABCB4基因第6、8和9外显子的分子特征分析
Biomarkers. 2016 Nov;21(7):573-7. doi: 10.3109/1354750X.2016.1166264. Epub 2016 Apr 14.
7
Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.肝靶向基因治疗可长期纠正小鼠进行性家族性肝内胆汁淤积症 3 型。
J Hepatol. 2019 Jul;71(1):153-162. doi: 10.1016/j.jhep.2019.03.021. Epub 2019 Mar 29.
8
Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.32 岁女性进行性家族性肝内胆汁淤积症 3 型:肝内胆管缺失和肝硬化病例报告及文献复习。
World J Gastroenterol. 2018 Nov 7;24(41):4716-4720. doi: 10.3748/wjg.v24.i41.4716.
9
[Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3].[3型进行性家族性肝内胆汁淤积症患儿的临床特征分析]
Zhonghua Er Ke Za Zhi. 2024 May 2;62(5):462-466. doi: 10.3760/cma.j.cn112140-20231010-00270.
10
Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).3型进行性家族性肝内胆汁淤积症(PFIC3)中25种新的ABCB4突变的分子特征及结构意义
Eur J Hum Genet. 2007 Dec;15(12):1230-8. doi: 10.1038/sj.ejhg.5201908. Epub 2007 Aug 29.

引用本文的文献

1
Novel ABCB4 mutation in a female patient with progressive familial intrahepatic cholestasis type 3: a case report and literature review.一名患有3型进行性家族性肝内胆汁淤积症的女性患者中的新型ABCB4突变:病例报告及文献综述
Ann Med Surg (Lond). 2024 Dec 19;87(2):953-963. doi: 10.1097/MS9.0000000000002813. eCollection 2025 Feb.
2
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC).鉴定出 OATP1B1 的可逆转性和 CYP3A4 的时间依赖性抑制作用是导致药物性胆汁淤积(DIC)的主要危险因素。
Arch Toxicol. 2024 Oct;98(10):3409-3424. doi: 10.1007/s00204-024-03794-3. Epub 2024 Jul 18.
3
A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.3 型进行性家族性肝内胆汁淤积症的一名女性患者,其致病原因为 ABCB4 基因突变杂合子,经熊去氧胆酸治疗后肝硬化得到改善:病例报告。
BMC Med Genomics. 2023 Jul 25;16(1):171. doi: 10.1186/s12920-023-01602-y.
4
Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.对进行性家族性肝内胆汁淤积症 3 型(PFIC3)患儿的临床和基因特征分析:14 种新型 ABCB4 变异的鉴定及文献回顾。
Orphanet J Rare Dis. 2022 Dec 22;17(1):445. doi: 10.1186/s13023-022-02597-y.
5
Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.中国一名进行性家族性肝内胆汁淤积症 3 型女性患者的新型 ABCB4 突变:病例报告。
Diagn Pathol. 2020 Apr 22;15(1):39. doi: 10.1186/s13000-020-00955-7.

本文引用的文献

1
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.人类基因突变数据库:为临床和分子遗传学、诊断测试以及个性化基因组医学构建全面的基因突变知识库。
Hum Genet. 2014 Jan;133(1):1-9. doi: 10.1007/s00439-013-1358-4.
2
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症。
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S26-35. doi: 10.1016/S2210-7401(12)70018-9.
3
MDR3 immunostaining on frozen liver biopsy samples is not a sensitive diagnostic tool for the detection of heterozygous MDR3/ABCB4 gene mutations.
Virchows Arch. 2012 May;460(5):535-7; author reply 539. doi: 10.1007/s00428-012-1231-1. Epub 2012 Apr 13.
4
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症。
Hepatobiliary Pancreat Dis Int. 2010 Dec;9(6):570-8.
5
Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.与 ABCB4 基因突变相关的进行性家族性肝内胆汁淤积症 3 型患儿的临床特征及基因型-表型相关性。
J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):73-83. doi: 10.1097/MPG.0b013e3181f50363.
6
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.与 ABCB4 基因突变相关的肝脏疾病谱:病理生理学和临床方面。
Semin Liver Dis. 2010 May;30(2):134-46. doi: 10.1055/s-0030-1253223. Epub 2010 Apr 26.
7
[Progressive familial intrahepatic cholestasis type 3].
Zhonghua Gan Zang Bing Za Zhi. 2010 Mar;18(3):238-40. doi: 10.3760/cma.j.issn.1007-3418.2010.03.023.
8
A method and server for predicting damaging missense mutations.一种预测有害错义突变的方法及服务器。
Nat Methods. 2010 Apr;7(4):248-9. doi: 10.1038/nmeth0410-248.
9
Jalview Version 2--a multiple sequence alignment editor and analysis workbench.Jalview 2版本——一个多序列比对编辑器和分析工作台。
Bioinformatics. 2009 May 1;25(9):1189-91. doi: 10.1093/bioinformatics/btp033. Epub 2009 Jan 16.
10
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
Orphanet J Rare Dis. 2009 Jan 8;4:1. doi: 10.1186/1750-1172-4-1.